Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis
It has been established that mortality among US end-stage renal disease patients is higher than in many other developed countries. The explanation for this apparent difference in outcome results has caused considerable concern. The explanations for this difference are complex and could include diffe...
Gespeichert in:
| Veröffentlicht in: | American journal of kidney diseases 1994-12, Vol.24 (6), p.1010-1018 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1018 |
|---|---|
| container_issue | 6 |
| container_start_page | 1010 |
| container_title | American journal of kidney diseases |
| container_volume | 24 |
| creator | KEANE, W. F COLLINS, A. J |
| description | It has been established that mortality among US end-stage renal disease patients is higher than in many other developed countries. The explanation for this apparent difference in outcome results has caused considerable concern. The explanations for this difference are complex and could include differences in case mix as well as indices of severity of illness. To evaluate potential patient-based explanations for these discrepancies, we have evaluated existing reports as well as the available database at the Regional Kidney Disease Program at Hennepin County Medical Center, with particular emphasis on medical co-morbidity present in US end-stage renal disease patients. These data indicate that increasing age, a greater prevalence of diabetes mellitus patients, and a greater proportion of end-stage renal disease patients with complex medical co-morbidity contribute to the higher mortality seen in US patients receiving hemodialytic therapies. |
| doi_str_mv | 10.1016/S0272-6386(12)81076-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76871757</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76871757</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-4a252ff2be0e385e45ae992961f1100571853a7aacf3c5a6946a48e8f18266683</originalsourceid><addsrcrecordid>eNpFkE1rGzEQhkVJSR23P8GgQwnJYRt9WCPtsZgkNQR6aHrpRYy1I6yyH-5KJvjfd50Y5yRe3mdGzMPYQopvUki4-yWUVRVoBzdS3TopLFTwgc2kUboCp90Fm52RT-wq579CiFoDXLJLWzsDoGbsz7qP7Z76QHyIPAxVN4yb1KRy4EPPp1CwPQbsG_5epZ7vsCTqS-ZlJCzU8JdUtnxL3dAkbA855c_sY8Q205fTO2e_H-6fVz-qp5-P69X3pyporUu1RGVUjGpDgrQztDRIda1qkFFKIYyVzmi0iCHqYBDqJeDSkYvSKYDp0Dm7ftu7G4d_e8rFdykHalvsadhnb8FZaY2dQPMGhnHIeaTod2PqcDx4KfzRqX916o_CvFT-1emU5mxx-mC_6ag5T50kTv3XU485YBtH7EPKZ0xrkFo7_R9uEX9Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76871757</pqid></control><display><type>article</type><title>Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>KEANE, W. F ; COLLINS, A. J</creator><creatorcontrib>KEANE, W. F ; COLLINS, A. J</creatorcontrib><description>It has been established that mortality among US end-stage renal disease patients is higher than in many other developed countries. The explanation for this apparent difference in outcome results has caused considerable concern. The explanations for this difference are complex and could include differences in case mix as well as indices of severity of illness. To evaluate potential patient-based explanations for these discrepancies, we have evaluated existing reports as well as the available database at the Regional Kidney Disease Program at Hennepin County Medical Center, with particular emphasis on medical co-morbidity present in US end-stage renal disease patients. These data indicate that increasing age, a greater prevalence of diabetes mellitus patients, and a greater proportion of end-stage renal disease patients with complex medical co-morbidity contribute to the higher mortality seen in US patients receiving hemodialytic therapies.</description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1016/S0272-6386(12)81076-6</identifier><identifier>PMID: 7985662</identifier><language>eng</language><publisher>Orlando, FL: Elsevier</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Comorbidity ; Emergency and intensive care: renal failure. Dialysis management ; Humans ; Incidence ; Intensive care medicine ; Kidney Failure, Chronic - epidemiology ; Kidney Failure, Chronic - mortality ; Medical sciences ; Morbidity ; Renal Dialysis - mortality ; Risk ; United States - epidemiology</subject><ispartof>American journal of kidney diseases, 1994-12, Vol.24 (6), p.1010-1018</ispartof><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-4a252ff2be0e385e45ae992961f1100571853a7aacf3c5a6946a48e8f18266683</citedby><cites>FETCH-LOGICAL-c333t-4a252ff2be0e385e45ae992961f1100571853a7aacf3c5a6946a48e8f18266683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3361338$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7985662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KEANE, W. F</creatorcontrib><creatorcontrib>COLLINS, A. J</creatorcontrib><title>Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description>It has been established that mortality among US end-stage renal disease patients is higher than in many other developed countries. The explanation for this apparent difference in outcome results has caused considerable concern. The explanations for this difference are complex and could include differences in case mix as well as indices of severity of illness. To evaluate potential patient-based explanations for these discrepancies, we have evaluated existing reports as well as the available database at the Regional Kidney Disease Program at Hennepin County Medical Center, with particular emphasis on medical co-morbidity present in US end-stage renal disease patients. These data indicate that increasing age, a greater prevalence of diabetes mellitus patients, and a greater proportion of end-stage renal disease patients with complex medical co-morbidity contribute to the higher mortality seen in US patients receiving hemodialytic therapies.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Comorbidity</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Humans</subject><subject>Incidence</subject><subject>Intensive care medicine</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Medical sciences</subject><subject>Morbidity</subject><subject>Renal Dialysis - mortality</subject><subject>Risk</subject><subject>United States - epidemiology</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1rGzEQhkVJSR23P8GgQwnJYRt9WCPtsZgkNQR6aHrpRYy1I6yyH-5KJvjfd50Y5yRe3mdGzMPYQopvUki4-yWUVRVoBzdS3TopLFTwgc2kUboCp90Fm52RT-wq579CiFoDXLJLWzsDoGbsz7qP7Z76QHyIPAxVN4yb1KRy4EPPp1CwPQbsG_5epZ7vsCTqS-ZlJCzU8JdUtnxL3dAkbA855c_sY8Q205fTO2e_H-6fVz-qp5-P69X3pyporUu1RGVUjGpDgrQztDRIda1qkFFKIYyVzmi0iCHqYBDqJeDSkYvSKYDp0Dm7ftu7G4d_e8rFdykHalvsadhnb8FZaY2dQPMGhnHIeaTod2PqcDx4KfzRqX916o_CvFT-1emU5mxx-mC_6ag5T50kTv3XU485YBtH7EPKZ0xrkFo7_R9uEX9Y</recordid><startdate>19941201</startdate><enddate>19941201</enddate><creator>KEANE, W. F</creator><creator>COLLINS, A. J</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19941201</creationdate><title>Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis</title><author>KEANE, W. F ; COLLINS, A. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-4a252ff2be0e385e45ae992961f1100571853a7aacf3c5a6946a48e8f18266683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Comorbidity</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Humans</topic><topic>Incidence</topic><topic>Intensive care medicine</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Medical sciences</topic><topic>Morbidity</topic><topic>Renal Dialysis - mortality</topic><topic>Risk</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KEANE, W. F</creatorcontrib><creatorcontrib>COLLINS, A. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KEANE, W. F</au><au>COLLINS, A. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>1994-12-01</date><risdate>1994</risdate><volume>24</volume><issue>6</issue><spage>1010</spage><epage>1018</epage><pages>1010-1018</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract>It has been established that mortality among US end-stage renal disease patients is higher than in many other developed countries. The explanation for this apparent difference in outcome results has caused considerable concern. The explanations for this difference are complex and could include differences in case mix as well as indices of severity of illness. To evaluate potential patient-based explanations for these discrepancies, we have evaluated existing reports as well as the available database at the Regional Kidney Disease Program at Hennepin County Medical Center, with particular emphasis on medical co-morbidity present in US end-stage renal disease patients. These data indicate that increasing age, a greater prevalence of diabetes mellitus patients, and a greater proportion of end-stage renal disease patients with complex medical co-morbidity contribute to the higher mortality seen in US patients receiving hemodialytic therapies.</abstract><cop>Orlando, FL</cop><pub>Elsevier</pub><pmid>7985662</pmid><doi>10.1016/S0272-6386(12)81076-6</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0272-6386 |
| ispartof | American journal of kidney diseases, 1994-12, Vol.24 (6), p.1010-1018 |
| issn | 0272-6386 1523-6838 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_76871757 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Comorbidity Emergency and intensive care: renal failure. Dialysis management Humans Incidence Intensive care medicine Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - mortality Medical sciences Morbidity Renal Dialysis - mortality Risk United States - epidemiology |
| title | Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A54%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20co-morbidity%20on%20mortality%20and%20morbidity%20in%20patients%20treated%20with%20hemodialysis&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=KEANE,%20W.%20F&rft.date=1994-12-01&rft.volume=24&rft.issue=6&rft.spage=1010&rft.epage=1018&rft.pages=1010-1018&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1016/S0272-6386(12)81076-6&rft_dat=%3Cproquest_cross%3E76871757%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76871757&rft_id=info:pmid/7985662&rfr_iscdi=true |